VHL mutant heterozygotes are predisposed to multiple tumors, including cerebellar, spinal and retinal hemangioblastomas, renal cell carcinomas, pheochromocytomas and lymphatic sac tumors. The gene discussed is VHL; the disease is renal cell carcinoma.